Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 4,600 shares at $46.81 ($213K) on 2013-10-01, disclosed to the SEC on 2013-10-02.
Scheduled sale ($213k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.05 | 3,092 | $142K | 66.9% |
| 2 | $46.81 | 1,508 | $71K | 33.1% |
| Total | $46.30 avg | 4,600 | $213K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |